Product Reports Resources Pricing Login Book a demo

Onyx Pharmaceuticals

Biotech & Life Sciences · South San Francisco, United States · Founded 1992

Biopharmaceutical company committed to improving the lives of people with cancer

Headcount 100–500
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Onyx Pharmaceuticals and the history behind them.
Power Law Decacorn$10B+ valuation tier Thoroughbred$100M+ revenue

Talent graph

Onyx Pharmaceuticals's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 8 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

4 investors on Onyx Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Sequoia
Series B+ 3 investors entered at this stage
Domain Associates
Federated Hermes
OrbiMed

Onyx Pharmaceuticals mafia

Startups founded by Onyx Pharmaceuticals alumni

Former Onyx Pharmaceuticals employees who went on to start their own companies. Sorted by Dealroom signal score.

Mirum PharmaceuticalsEst. 2018
CPChris PeetzUnited States
Signal score90
HelixEst. 2015
Justin KaoUnited States
Signal score84
Cadence HealthEst. 2016
Samantha MillerUnited States
Signal score72
4D Molecular TherapeuticsEst. 2013
David KirnUnited States
Signal score68
ImaginDairyEst. 2020
Arie AboIsrael
Signal score63
Avidity BiosciencesEst. 2013
Frank McCormickUnited States
Signal score62
Dauntless PharmaceuticalsEst. 2015
Larry BockUnited States
Signal score58
Oorja BioEst. 2023
CCConnie CoulombUnited States
Signal score55

Book a demo to explore the full alumni network →

Global footprint

Where Onyx Pharmaceuticals has talent and traffic

Workforce by country
7 countries with
team presence
🇺🇸 United States79.5%
🇨🇦 Canada6.8%
🇬🇧 United Kingdom4.5%
🇨🇭 Switzerland2.3%
🇵🇰 Pakistan2.3%
Top 5 of 7 shown

Patent intelligence

$66M patent portfolio · 22 active families

Estimated portfolio value
$66M
3.8× smaller than top peer Reata Pharmaceuticals ($253M)
22 active patent families
Where Onyx Pharmaceuticals innovates AziridineEnzyme inhibitionEpoxideHeteroatomKetone

Where Onyx Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Onyx Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Onyx Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Onyx Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Onyx Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles